<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01227226</url>
  </required_header>
  <id_info>
    <org_study_id>06</org_study_id>
    <nct_id>NCT01227226</nct_id>
  </id_info>
  <brief_title>Tear Osmolarity Over Time With Artificial Tears</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hom, Milton M., OD, FAAO</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hom, Milton M., OD, FAAO</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of artificial tears on tear osmolarity
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tear osmolarity measures the amount of solutes in the human tear film. The higher the
      reading, the more likely the patient has dry eyes. Some say it has &quot;potential to be the gold
      standard&quot; of dry eye testing. The investigators study the tear osmolarity at different time
      points after instillation of artificial tears.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">March 2011</completion_date>
  <primary_completion_date type="Anticipated">March 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tear osmolarity</measure>
    <time_frame>2 days</time_frame>
    <description>Tear osmolarity measured with TearLab instrument</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Dry Eye</condition>
  <arm_group>
    <arm_group_label>Refresh tears</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Allergan's Refresh tears artificial tear</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Systane Ultra</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Alcon's Systane Ultra artificial tear</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Visine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Visine artificial tear</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blink tears</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AMO's blink tears artificial tear</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Artificial tears</intervention_name>
    <description>Instill one drop of artificial tears</description>
    <arm_group_label>Refresh tears</arm_group_label>
    <arm_group_label>Systane Ultra</arm_group_label>
    <arm_group_label>Visine</arm_group_label>
    <arm_group_label>Blink tears</arm_group_label>
    <other_name>Allergan's Refresh tears, Alcon's Systane Ultra, Johnson and Johnson's Visine, AMO's blink tears</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Between the ages of 18 and over inclusive. Males or females Any race or ethnic background
        Patient is in generally good &amp; stable overall health. Patient likely to comply with study
        guidelines &amp; study visits. Informed consent signed. Subjective evaluation of symptom of
        dryness (SESoD): Score 2 (Mild)

        Exclusion Criteria:

        Corneal refractive surgery within 6 months of this study. Intra-ocular surgery within 6
        months or ocular laser surgery within 6 months. Pregnant or lactating women. Ocular
        pathology (includes glaucoma and cataract), which could impact results and/or place patient
        at risk.

        Corneal staining Grade 3 or higher No Restasis for past 3 months Discontinue topical
        medications for at least 1 week
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Milton M Hom, OD FAAO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Private Practice</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Milton M. Hom, OD, FAAO.</name>
      <address>
        <city>Azusa</city>
        <state>California</state>
        <zip>91702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2010</study_first_submitted>
  <study_first_submitted_qc>October 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2010</study_first_posted>
  <last_update_submitted>February 4, 2011</last_update_submitted>
  <last_update_submitted_qc>February 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2011</last_update_posted>
  <responsible_party>
    <name_title>Milton M. Hom, OD, FAAO.</name_title>
    <organization>Private Practice</organization>
  </responsible_party>
  <keyword>Dry eye</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lubricant Eye Drops</mesh_term>
    <mesh_term>Tetrahydrozoline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

